Tuesday - May 14, 2024
NEJM Evidence Issues Research Articles in January 2024 Edition
March 28, 2024
WALTHAM, Massachusetts, March 28 -- NEJM Evidence, a peer-reviewed journal from New England Journal of Medicine Group that says it presents clinical trial design and decision-making, published research articles on the following topics in its January 2024 edition (Vol. 3, No. 1):

Original Articles:

* Targeted Inhibition of CYP11A1 in Castration-Resistant Prostate Cancer

* Apixaban versus Aspirin for Embolic Stroke of Undetermined Source

* High- . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products